Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

The influence of prolonged temperature management on acute kidney injury after out-of-hospital cardiac arrest: A post-hoc analysis of the TTH48 trial.

Strand K, Søreide E, Kirkegaard H, Taccone FS, Grejs AM, Duez CHV, Jeppesen AN, Storm C, Rasmussen BS, Laitio T, Hassager C, Toome V, Hästbacka J, Skrifvars MB.

Resuscitation. 2020 Feb 19. pii: S0300-9572(20)30076-9. doi: 10.1016/j.resuscitation.2020.01.039. [Epub ahead of print]

PMID:
32087257
2.

Cold fluids for induction of targeted temperature management: A sub-study of the TTH48 trial.

Holm A, Kirkegaard H, Taccone F, Søreide E, Grejs A, Duez C, Jeppesen A, Toome V, Hassager C C, Rasmussen BS, Laitio T, Storm C, Hästbacka J, Skrifvars MB.

Resuscitation. 2020 Mar 1;148:90-97. doi: 10.1016/j.resuscitation.2019.11.031. Epub 2020 Jan 18.

PMID:
31962179
3.

Hypothermic to ischemic ratio and mortality in post-cardiac arrest patients.

Skrifvars MB, Soreide E, Sawyer KN, Taccone FS, Toome V, Storm C, Jeppesen A, Grejs A, Duez CHV, Tiainen M, Rasmussen BS, Laitio T, Hassager C, Kirkegaard H.

Acta Anaesthesiol Scand. 2020 Apr;64(4):546-555. doi: 10.1111/aas.13528. Epub 2019 Dec 26.

PMID:
31830304
4.

Targeted Temperature Management for 48 vs 24 Hours and Neurologic Outcome After Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial.

Kirkegaard H, Søreide E, de Haas I, Pettilä V, Taccone FS, Arus U, Storm C, Hassager C, Nielsen JF, Sørensen CA, Ilkjær S, Jeppesen AN, Grejs AM, Duez CHV, Hjort J, Larsen AI, Toome V, Tiainen M, Hästbacka J, Laitio T, Skrifvars MB.

JAMA. 2017 Jul 25;318(4):341-350. doi: 10.1001/jama.2017.8978.

5.

A statistical analysis protocol for the time-differentiated target temperature management after out-of-hospital cardiac arrest (TTH48) clinical trial.

Kirkegaard H, Pedersen AR, Pettilä V, Hjort J, Rasmussen BS, de Haas I, Nielsen JF, Ilkjær S, Kaltoft A, Jeppesen AN, Grejs AM, Duez CH, Larsen AI, Toome V, Arus U, Taccone FS, Storm C, Laitio T, Skrifvars MB, Søreide E.

Scand J Trauma Resusc Emerg Med. 2016 Nov 28;24(1):138.

6.

Time-differentiated target temperature management after out-of-hospital cardiac arrest: a multicentre, randomised, parallel-group, assessor-blinded clinical trial (the TTH48 trial): study protocol for a randomised controlled trial.

Kirkegaard H, Rasmussen BS, de Haas I, Nielsen JF, Ilkjær S, Kaltoft A, Jeppesen AN, Grejs A, Duez CH, Larsen AI, Pettilä V, Toome V, Arus U, Taccone FS, Storm C, Skrifvars MB, Søreide E.

Trials. 2016 May 4;17(1):228. doi: 10.1186/s13063-016-1338-9.

7.

Tracking rhythm in long-term EEG recordings using empirical mode calculation.

Lipping T, Anier A, Ratsep I, Kleemann P, Toome V, Jantti V.

Conf Proc IEEE Eng Med Biol Soc. 2008;2008:3604-7. doi: 10.1109/IEMBS.2008.4649986.

PMID:
19163489
8.

Characterization of recombinant HIV-1 Tat and its interaction with TAR RNA.

Slice LW, Codner E, Antelman D, Holly M, Wegrzynski B, Wang J, Toome V, Hsu MC, Nalin CM.

Biochemistry. 1992 Dec 8;31(48):12062-8.

PMID:
1457403
10.

Solution structures of cyclic and dicyclic analogues of growth hormone releasing factor as determined by two-dimensional NMR and CD spectroscopies and constrained molecular dynamics.

Fry DC, Madison VS, Greeley DN, Felix AM, Heimer EP, Frohman L, Campbell RM, Mowles TF, Toome V, Wegrzynski BB.

Biopolymers. 1992 Jun;32(6):649-66.

PMID:
1643268
12.

Purification and characterization of recombinant Rev protein of human immunodeficiency virus type 1.

Nalin CM, Purcell RD, Antelman D, Mueller D, Tomchak L, Wegrzynski B, McCarney E, Toome V, Kramer R, Hsu MC.

Proc Natl Acad Sci U S A. 1990 Oct;87(19):7593-7.

13.

aS,7S-absolute configuration of natural (-)-colchicine and allo-congeners.

Brossi A, Boyé O, Muzaffar A, Yeh HJ, Toome V, Wegrzynski B, George C.

FEBS Lett. 1990 Mar 12;262(1):5-7.

14.
15.

Synthesis, biological activity and conformational analysis of cyclic GRF analogs.

Felix AM, Heimer EP, Wang CT, Lambros TJ, Fournier A, Mowles TF, Maines S, Campbell RM, Wegrzynski BB, Toome V, et al.

Int J Pept Protein Res. 1988 Dec;32(6):441-54.

PMID:
3149952
16.

Identification of specific residues of human interleukin 2 that affect binding to the 70-kDa subunit (p70) of the interleukin 2 receptor.

Collins L, Tsien WH, Seals C, Hakimi J, Weber D, Bailon P, Hoskings J, Greene WC, Toome V, Ju G.

Proc Natl Acad Sci U S A. 1988 Oct;85(20):7709-13.

18.
19.

The metabolism of 14C-cibenzoline in dogs and rats.

Loh AC, Williams TH, Tilley JW, Sasso GJ, Szuna AJ, Carbone JJ, Toome V, Leinweber FJ.

Drug Metab Dispos. 1986 May-Jun;14(3):325-30.

PMID:
2872033
21.

Metabolites of an antipsychotic chiral pyrroloisoquinoline and their effect on prolactin secretion in the rat.

Kolis SJ, Williams TH, Mowles TF, Burghardt B, Toome V, Schwartz MA.

J Pharmacol Exp Ther. 1983 Dec;227(3):652-7.

PMID:
6140308
22.

Application of MDPF and fluorescamine XV chiroptical properties of MDPF condensation compounds with dipeptides in situ.

Toome V, Wegrzynski B.

Biochem Biophys Res Commun. 1983 Jul 29;114(2):433-9.

PMID:
6882434
23.

Ro 22-5417, a new clavam antibiotic from Streptomyces clavuligerus. III. Absolute stereochemistry.

Müller JC, Toome V, Pruess DL, Blount JF, Weigele M.

J Antibiot (Tokyo). 1983 Mar;36(3):217-25.

24.

Application of fluorescamine XII. Chiroptical properties of fluorescamine condensation compounds with some less common alpha-amino acids.

Toome V, Wegrzynski B.

Biochem Biophys Res Commun. 1980 Jan 29;92(2):447-51. No abstract available.

PMID:
7356476
25.

Circular dichroism studies of keto-bile acids.

Dayal B, Toome V, Salen G.

Steroids. 1980 Jan;35(1):81-8.

PMID:
7376211
26.

Chiroptical properties of fluorescamine condensation compounds with amino acid esters in situ. Pyrrolinone chirality rule.

Toome V, Wegrzynski B.

Biochem Biophys Res Commun. 1978 Dec 29;85(4):1496-502. No abstract available.

PMID:
743312
27.
28.

Preparation and characterization of (24R and 24S)-5beta-cholestane-3alpha,7alpha,24,25-tetrols and (24R and 24S)-5beta-cholestane-3alpha,24,25-triols.

Batta AK, Dayal B, Tint GS, Shefer S, Toome V, Salen G, Mosbach EH.

Steroids. 1978 Jan;31(1):99-111.

PMID:
663960
29.

Chiroptical properties of fluorescamine condensation compounds with dipeptides in situ.

Toome V, Wegrzynski B, Dell J.

Biochem Biophys Res Commun. 1977 Jan 24;74(2):825-30. No abstract available.

PMID:
836329
30.

Chiroptical properties of fluorescamine condensation compounds with secondary amino acids in situ.

Toome V, Wegrzynski B, Dell J.

Biochem Biophys Res Commun. 1976 Jul 26;71(2):598-602. No abstract available.

PMID:
9082
31.

A stereoselective synthesis of the 24(R),25-dihydroxycholesterol side chain.

Partridge JJ, Toome V, Uskokovic MR.

J Am Chem Soc. 1976 Jun 9;98(12):3739-41. No abstract available.

PMID:
1270711
32.

Chiroptical properties of fluorescamine condensation compounds with alpha-amino acids in situ.

Toome V, Wegrzynski B, Reymond G.

Biochem Biophys Res Commun. 1976 Mar 8;69(1):206-11. No abstract available.

PMID:
1259758
33.

A test tube reaction for the determination of the absolute configuration of alpha-amino acids.

Toome V, Reymond G.

Biochem Biophys Res Commun. 1975 Sep 2;66(1):75-80. No abstract available.

PMID:
1164438
34.

Colorimetic amino acid analysis using fluorescamine.

Felix AM, Toome V, De Bernardo S, Weigele M.

Arch Biochem Biophys. 1975 Jun;168(2):601-8. No abstract available.

PMID:
1137411
35.

Studies on the reaction of fluorescamine with primary amines.

De Bernardo S, Weigele M, Toome V, Manhart K, Leimgruber W, Böhlen P, Stein S, Udenfriend S.

Arch Biochem Biophys. 1974 Jul;163(1):390-9. No abstract available.

PMID:
4859505
36.

Biotransformation of 2-hydroxynicotinic acid: N-riboside formation in vivo.

Schwartz MA, Kolis SJ, Williams TH, Gabriel TF, Toome V.

Drug Metab Dispos. 1973 May-Jun;1(3):557-64. No abstract available.

PMID:
4149449
37.

Chemical transformations of antibiotic X-537A and their effect on antibacterial activity.

Westley JW, Oliveto EP, Berger J, Evans RH Jr, Glass R, Stempel A, Toome V, Williams T.

J Med Chem. 1973 Apr;16(4):397-403. No abstract available.

PMID:
4716184
38.

Studies in the nitroimidazole series. I. Synthesis of azomycin A and related compounds.

Beaman AG, Tautz W, Gabriel T, Keller O, Toome V, Duschinsky R.

Antimicrob Agents Chemother (Bethesda). 1965;5:469-77. No abstract available.

PMID:
5883461

Supplemental Content

Support Center